Academic literature on the topic 'Maladie thrombo-Embolique'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Maladie thrombo-Embolique.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Maladie thrombo-Embolique"
Wagner, T. "Maladie thrombo-embolique veineuse." Revue des Maladies Respiratoires 25, no. 2 (February 2008): 27. http://dx.doi.org/10.1016/s0761-8425(08)74821-6.
Full textTromeur, C. "Maladie veineuse thrombo-embolique." Revue des Maladies Respiratoires Actualités 4, no. 7 (December 2012): 725–32. http://dx.doi.org/10.1016/s1877-1203(12)70341-5.
Full textLorut, C., G. Meyer, C. Leroyer, and F. Parent. "La maladie thrombo-embolique veineuse." Revue des Maladies Respiratoires 22, no. 1 (February 2005): 169–73. http://dx.doi.org/10.1016/s0761-8425(05)85452-x.
Full textDanchin, N. "La maladie veineuse thrombo-embolique." Annales de Cardiologie et d'Angéiologie 51, no. 3 (2002): 123. http://dx.doi.org/10.1016/s0003-3928(02)00082-3.
Full textÉmile, Carole. "Grossesse et maladie thrombo-embolique veineuse." Option/Bio 32, no. 629-630 (March 2021): 26–28. http://dx.doi.org/10.1016/s0992-5945(21)00051-9.
Full textJahnaoui, N., S. Hammi, I. Id Ahmed, K. Marc, M. Soualhi, R. Zahraoui, J. Benamor, J. E. Bourkadi, and G. Iraqi. "Tuberculose pulmonaire et maladie thrombo-embolique." Revue des Maladies Respiratoires 29 (January 2012): A112. http://dx.doi.org/10.1016/j.rmr.2011.10.370.
Full textMeyer, G. "Maladie veineuse thrombo-embolique et cancer." Journal des Maladies Vasculaires 36 (December 2011): S42—S47. http://dx.doi.org/10.1016/s0398-0499(11)70008-7.
Full textHorellou, M. H., G. Plu-Bureau, and J. Lepercq. "Maladie thrombo-embolique veineuse et grossesse." La Revue de Médecine Interne 36, no. 3 (March 2015): 219–24. http://dx.doi.org/10.1016/j.revmed.2014.10.356.
Full textSgard, B. "Maladie veineuse thrombo-embolique – Session 2." Médecine Nucléaire 41, no. 5 (September 2017): 349–52. http://dx.doi.org/10.1016/j.mednuc.2017.07.004.
Full textCombe, S., and H. R. Büller. "Nouveaux traitements de la maladie thrombo-embolique veineuse." Journal des Maladies Vasculaires 36 (December 2011): S16—S19. http://dx.doi.org/10.1016/s0398-0499(11)70003-8.
Full textDissertations / Theses on the topic "Maladie thrombo-Embolique"
Couturaud, Francis. "Risque de maladie thrombo-embolique veineuse chez les membres de familles au premier degré de patients ayant une maladie thrombo-embolique veineuse idiopathique." Lyon 1, 2006. http://www.theses.fr/2006LYO10184.
Full textRational : In patients with idiopathic venous thromboembolism (VTE), the risk of recurrent VTE is high and a large proportion of these patients carry inherited thrombophilia. Our hypothesis is that patients with idiopathic VTE without detectable inherited thrombophilia have a genetic prothrombotic state not yet discovered. Objective : To evaluate the risk of VTE in first degree relatives of patients with idiopathic VTE and with or without inherited thrombophilia. If our hypothesis is true, this risk should be similar, with or without thrombophilia. Methods : In this international multicentre study, 1778 first degree relatives of 348 propositus with objectively diagnosed idiopathic VTE were included. Relatives were classified as having “certain VTE”, “uncertain VTE” or “no VTE” according to a predefined and standardised questionnaire. All the propositus were tested for the Leiden mutation and the G20210A prothrombin gene mutation. Results : In multivariate analysis, when “uncertain VTE” were classified as “No VTE”, we observed a trend of an increased risk of VTE in first degree relatives of probants with an inherited thrombophilia (relative risk of 1,52 [0,98 – 2,37], p = 0,06); when “uncertain VTE” were classified as “certain VTE”, the relative risk of VTE was closed to 1. 0 (1,18 [0,87-1,60], p = 0,3). For each level of VTE diagnosis criteria precision, there was an increased risk of VTE in first degree relatives women and in relatives from younger probants. Conclusion : The presence of an inherited thrombophilia in patients with idiopathic VTE is weakly associated with an increased risk in their first degree relatives. This observation supports our scientific hypothesis. One the main implications of this study is that the prevention of VTE should not be proposed in only first degree relatives of patients with VTE and inherited thrombophilia
Yvorra, Serge. "La maladie veineuse thrombo-embolique ambulatoire : donnees epidemiologiques, etiologiques, et suivi." Aix-Marseille 2, 1992. http://www.theses.fr/1992AIX20856.
Full textPérol, Maurice. "Maladie thrombo-embolique pulmonaire chronique, éléments du pronostic : à propos de 27 observations." Lyon 1, 1989. http://www.theses.fr/1989LYO1M360.
Full textRiemens, Paul. "La maladie thrombo-embolique et son coût : considérations générales et en long séjour." Bordeaux 2, 1990. http://www.theses.fr/1990BOR25281.
Full textChalayer, Emilie. "Myélome multiple et maladie thrombo-embolique veineuse : aspects épidémiologiques, économiques, physiopathologiques et pharmacologiques." Thesis, Saint-Etienne, 2015. http://www.theses.fr/2015STET007T/document.
Full textThe association between multiple myeloma and venous thromboembolic disease is well established. This incidence in myeloma is on average from 10 to 20%. It appears to be higher in newly diagnosed myeloma and immunomodulatory drugs such as thalidomide might significantly increase the risk. However, the risk of thrombosis due to these treatments is not yet well defined. First, we performed a review of these diseases in order to delimit the field of this study through a literature review. Then, we evaluated the incidence of venous thromboembolic disease in patients with myeloma and treated with immunomodulatory, identified the thrombotic risk factors and evaluated the thrombotic risk assessment based on the physicians choice, through an observational, multicenter, prospective French study. Moreover, we performed the medico-economic analysis of the only randomized trial conducted to date on the thrombophylaxis in patients with multiple myeloma treated with thalidomide in the first line of chemotherapy. This analysis showed a gain in quality of life associated with significant cost savings in the prevention of thrombosis by aspirin rather than heparin. Finally we performed two medical studies using thrombin generation test, a global assay that measures the overall tendency of a plasma sample to form thrombin. The first study was conducted to predict patients who will have thrombosis. The second is performed to know if a heparin resistance with the usual doses in this pathology, exists
Lanoy, Léonard Fisch Alain. "Maladie veineuse thrombo-embolique et voyage aérien de courte durée réalités et perspectives /." Créteil : Université de Paris-Val-de-Marne, 2009. http://doxa.scd.univ-paris12.fr:80/theses/th0512111.pdf.
Full textSCHAMBRI, YVES. "Maladie thrombo-embolique : quel bilan etiologique ? l'experience du chg de pamiers : 40 cas." Toulouse 3, 1989. http://www.theses.fr/1989TOU31107.
Full textBREHM, GAILHARD SYLVIE, and FRANCOIS GALLEGO. "Le risque thrombo-embolique chez le sujet age hospitalise : consequences sur l'utilisation des anticoagulants." Toulouse 3, 1988. http://www.theses.fr/1988TOU31194.
Full textDESCHLER, SERGE. "L'heparinotherapie dans la prevention de la maladie thrombo-embolique en traumatologie et en orthopedie." Strasbourg 1, 1987. http://www.theses.fr/1987STR10680.
Full textLAPEYRE, FRANCOIS. "Filtres caves percutanes et maladie thrombo-embolique : indications et resultats ; revue de 180 observations." Toulouse 3, 1989. http://www.theses.fr/1989TOU31096.
Full textBook chapters on the topic "Maladie thrombo-Embolique"
Vernhet Kovacsik, H. "Embolie pulmonaire et maladie thrombo-embolique." In Collection de la Société française d’imagerie cardiaque et vasculaire, 207–20. Paris: Springer Paris, 2009. http://dx.doi.org/10.1007/978-2-287-99166-0_17.
Full textPlu-Bureau, G. "Contraception et maladie veineuse thrombo-embolique." In La Contraception en Pratique, 41–46. Elsevier, 2013. http://dx.doi.org/10.1016/b978-2-294-72785-6.00007-4.
Full textAya, G., D. Benhamou, F. Bolandard, M. Bonnin, E. Boselli, F. Broisin, B. Bryssine, et al. "Maladie thrombo-embolique veineuse en post-partum." In Protocoles en anesthésie et analgésie obstétricales, 121–25. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71053-7.00045-7.
Full textAya, G., F. Bayoumeu, D. Benhamou, F. Bolandard, M. P. Bonnet, M. Bonnin, E. Boselli, et al. "Maladie thrombo-embolique veineuse en post-partum." In Protocoles en Anesthésie et Analgésie Obstétricales, 175–79. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-76011-2.00056-7.
Full textCohen, Ariel, Emmanuelle Berthelot-Garcias, and Fanny Douna. "Examens diagnostiques dans la maladie veineuse thrombo-embolique." In Urgences cardio-vasculaires et situations critiques en cardiologie, 61–65. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71196-1.50017-0.
Full textCohen, Ariel, Emmanuelle Berthelot-Garcias, and Fanny Douna. "Procédure interventionnelle dans la maladie veineuse thrombo-embolique." In Urgences cardio-vasculaires et situations critiques en cardiologie, 141. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71196-1.50032-7.
Full text